The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy

2012/11/08 by R.E.J. Roach, R.E.J. ROACH, Willem M. Lijfering +9 · 6 citations
Medicine · #Menopause: Health Impacts and Treatments #Reproductive Health and Contraception #Sexual function and dysfunction studies

paper · doi:10.1111/jth.12060

openalex publication_date 2012/11/08 · crossref created 2012/11/08 · crossref issued 2013/01/01 · crossref published 2013/01/01 · crossref published-print 2013/01/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/27 · crossref indexed 2026/06/12 · openalex updated_date 2026/07/15

Citations

• Comparison of pharmacodynamic properties of various estrogen formulations
• Mechanisms of Estrogen-Induced Venous Thromboembolism

Cited by

• Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens
• Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis
• Hormones and venous thromboembolism among postmenopausal women
• How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
• Menopausal hormone therapy: a better and safer future
• Estrogen (medication) [wikipedia]